ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 956,89
0,53%
Dow Jones
38 538,11
0,82%
DAX
17 985,84
0,45%
Brent Oil
83,185
-0,53%
Bitcoin
61 695,76
4,35%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Atossa Therapeutics Inc (ATOS)

  7. Atossa Therapeutics Inc (ATOS) Actualités

ATOS Atossa Therapeutics Inc

1,6389
0,1189 (7,82%)
Dernière mise à jour : 16:38:29
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Atossa Therapeutics Inc ATOS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,1189 7,82% 1,6389 16:38:29
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,53 1,53 1,66 1,52
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
29/4/202414:30GLOBEAtossa Therapeutics Announces Expanded Research Agreement..
15/4/202414:30GLOBEAtossa Therapeutics and Quantum Leap Healthcare Announce..
11/4/202414:30GLOBEAtossa to Participate in Noble Capital Markets Emerging..
09/4/202417:59GLOBEAtossa Therapeutics Presents Data from 40mg Cohort of Phase..
01/4/202422:00GLOBEAtossa Therapeutics Announces Year-End 2023 Financial..
19/3/202413:30GLOBEAtossa Therapeutics Provides Five-Year (Z)-Endoxifen..
18/3/202413:30GLOBEAtossa Therapeutics Regains Compliance with Nasdaq Minimum..
12/3/202413:30GLOBEAtossa Therapeutics Appoints Breast Cancer Specialist Tessa..
22/2/202414:30GLOBEAtossa Therapeutics Announces First Patient Dosing of..
07/2/202414:30GLOBEAtossa Therapeutics Announces Full Enrollment..
09/1/202414:30GLOBEAtossa Therapeutics Issues Letter to Shareholders
04/12/202314:30GLOBEAtossa Therapeutics Announces the Appointment of Arezoo..
20/11/202314:30GLOBEAtossa Therapeutics Announces Full Enrollment of Phase 2..
15/11/202323:03EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
15/11/202322:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/11/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:00EDGAR2Form 8-K - Current report
13/11/202315:00GLOBEAtossa Therapeutics Announces Third Quarter 2023 Financial..
09/11/202315:00EDGAR2Form 8-K - Current report
09/11/202315:00GLOBEAtossa Therapeutics Appoints Financial Executive Jonathan..
30/10/202318:00PRNUSQuantum Leap Healthcare Collaborative Initiates Landmark..
16/10/202322:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/10/202314:30PRNUSFast-food consumption by adolescent girls may sow the seeds..
06/10/202322:00EDGAR2Form 8-K - Current report
28/9/202322:28EDGAR2Form 8-K - Current report
18/9/202314:30GLOBEAtossa to Present at Cantor Fitzgerald Global Healthcare..
14/8/202314:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202314:30EDGAR2Form 8-K - Current report
14/8/202314:30GLOBEAtossa Therapeutics Announces Second Quarter 2023 Financial..
08/8/202315:00GLOBEAtossa Therapeutics to Provide Business Update and Report..
20/7/202315:15GLOBEAtossa Therapeutics Receives Approval from Health Canada to..
13/7/202322:20EDGAR2Form 8-K - Current report
13/7/202322:15GLOBEAtossa Therapeutics Regains Compliance with Nasdaq Minimum..
10/7/202315:15GLOBEAtossa Therapeutics Provides Enrollment Update for Ongoing..
06/7/202315:15GLOBEAtossa Therapeutics Announces Sponsored Research Agreement..
28/6/202315:15GLOBEAtossa Therapeutics and Quantum Leap Healthcare Provide..
28/6/202315:01EDGAR2Form 8-K - Current report
27/6/202315:15GLOBEAtossa Therapeutics Announces $10M Stock Repurchase Program
22/6/202322:15GLOBEAtossa Therapeutics Announces Sponsorship of Are You Dense..
21/6/202316:13GLOBEAtossa Therapeutics Granted Additional Patent Protection for..
14/6/202315:15GLOBEAtossa to Participate in Fireside Chat at Healthcare Virtual..
12/6/202315:15GLOBEAtossa Completes Enrollment of Pharmacokinetic Run-In Cohort..
01/6/202315:10GLOBEAtossa Appoints Life Sciences Financial and Operations..
23/5/202313:00GLOBESocietal CDMO Enters Agreement With Atossa Therapeutics to..
15/5/202315:10GLOBEAtossa Therapeutics Announces First Quarter 2023 Financial..
11/5/202315:00PRNUSPhysician-Scientist Dr. Steven Quay Provides Recommendations..
09/5/202315:15GLOBEAtossa to Present a Trial in Progress Poster on its..

Dernières Valeurs Consultées

NASDAQ
ATOS
Atossa Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés